SOTK

Sono-Tek Corp. 10-K Summary (Fiscal Year Ended Feb 28, 1998)

Business Context and Reporting Period

Sono-Tek Corporation (Sono-Tek) develops, manufactures, and sells ultrasonic liquid atomizing units and related systems for industrial and laboratory applications. The reporting period covers the fiscal year ended February 28, 1998. The Company operates in a single industry segment, focusing on the electronics fabrication, medical device, and semiconductor manufacturing markets. Key products include the SonoFlux System (for printed circuit board fluxing), Nozzle Systems, and newly introduced liquid delivery and spray coating systems (MCS Infinity, Accu-Mist).

Key Financial Metrics

Note: Gross margin remained relatively constant between periods. The Company moved from a stockholders' deficiency in 1997 to positive equity in 1998.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 15% ($459,707) driven primarily by a 36% surge in SonoFlux System sales ($2.81M vs $2.06M). This was partially offset by a 27% decline in Nozzle Systems sales.
• Profitability: Operating income rose 40% to $300,567, and Net Income increased 65% to $252,047. This improvement was achieved despite a 15% increase in Cost of Goods Sold and higher operating expenses.
• Liquidity and Debt: Working capital improved by $271,581. The Company secured a new $150,000 revolving line of credit (utilized $50,000 as of May 1998) and a $57,000 equipment loan. Interest expense decreased 27% due to principal reductions on existing bank loans.
• Capital Structure: Stockholders' equity turned positive ($278,557) from a deficiency of ($41,278) in the prior year, largely due to profitable operations and the conversion of $67,788 in accrued interest into common stock.

Guidance, Outlook, and Risks

• Outlook: Management anticipates continued sales and profit growth in Fiscal 1999 driven by new product lines (liquid delivery systems) and expansion into new markets. The Company expects to pay off its primary bank loan in Fiscal 1999.
• Debt Maturity Risk: Convertible Secured Subordinated Notes totaling $530,000 mature on August 15, 2000. Management notes potential difficulty meeting this obligation unless profitability improves substantially or note holders agree to further extensions.
• Operational Risks: The Company's facility lease expired in January 1997; as of May 1998, no renewal was signed, and the Company operates on a month-to-month basis. There is a risk of needing to expand facilities due to new product demand.
• Competition and Patents: The Company relies on eight U.S. patents, with the earliest expiring in October 1999. Management acknowledges competition from entities with greater financial resources and the risk that existing patents may not be upheld if challenged.
• Year 2000 Compliance: The Company is evaluating Year 2000 compliance for its software systems, with estimated costs not expected to be material.

Investor Verification Checklist

• Debt Refinancing: Verify the status of the $530,000 convertible notes maturing in August 2000 and the likelihood of extension or repayment.
• Lease Status: Confirm if a long-term lease renewal has been secured for the Milton, NY facility to ensure operational continuity.
• Product Mix Sustainability: Assess the sustainability of the 36% growth in SonoFlux sales versus the 27% decline in Nozzle Systems sales.
• Cash Flow Trends: Monitor the decline in cash provided by operating activities (from $170,565 in 1997 to $88,197 in 1998) to ensure it does not signal liquidity constraints.
• Patent Expirations: Review the impact of the central-bolt nozzle patent expiring in October 1999 on competitive positioning.